Advanced Search (OLGA)

Gene: LINC01134 (long intergenic non-protein coding RNA 1134) Homo sapiens

Subscribe to Updates

Analyze

Symbol:

LINC01134

Name:

long intergenic non-protein coding RNA 1134

RGD ID:

7494427

HGNC Page

HGNC:49449

Description:

INTERACTS WITH aflatoxin B1; antirheumatic drug; benzo[e]pyrene

Type:

ncrna (Ensembl: lncRNA)

RefSeq Status:

VALIDATED

Previously known as:

RP13-15E13.1; TLNC1

Allele / Splice:

See ClinVar data

Latest Assembly:

GRCh38 - Human Genome Assembly GRCh38

Position:

Human Assembly	Chr	Position (strand)	Source	Genome Browsers
Human Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCh38	1	3,900,404 - 3,915,447 (+)	NCBI	GRCh38	GRCh38	hg38	GRCh38
GRCh38.p14 Ensembl	1	3,900,187 - 3,917,547 (+)	Ensembl	GRCh38		hg38	GRCh38
GRCh37	1	3,816,968 - 3,832,011 (+)	NCBI	GRCh37	GRCh37	hg19	GRCh37
Celera	1	3,070,604 - 3,085,646 (+)	NCBI		Celera
Cytogenetic Map	1	p36.32	NCBI
HuRef	1	3,112,576 - 3,127,620 (+)	NCBI		HuRef
CHM1_1	1	3,804,016 - 3,819,059 (+)	NCBI		CHM1_1
T2T-CHM13v2.0	1	3,412,308 - 3,427,355 (+)	NCBI		T2T-CHM13v2.0

JBrowse:

View Region in Genome Browser (JBrowse)

Model

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
LINC01134	Human	aflatoxin B1	increases methylation	EXP		6480464	Aflatoxin B1 results in increased methylation of LINC01134 gene and Aflatoxin B1 results in increased methylation of LINC01134 intron	CTD	PMID:27153756 and PMID:30157460
LINC01134	Human	antirheumatic drug	decreases expression	EXP		6480464	Antirheumatic Agents results in decreased expression of LINC01134 mRNA	CTD	PMID:24449571
LINC01134	Human	benzo[e]pyrene	affects methylation	EXP		6480464	benzo(e)pyrene affects the methylation of LINC01134 intron	CTD	PMID:30157460
LINC01134	Human	beta-lapachone	decreases expression	EXP		6480464	beta-lapachone results in decreased expression of LINC01134 mRNA	CTD	PMID:38218311
LINC01134	Human	cadmium dichloride	increases expression	EXP		6480464	Cadmium Chloride results in increased expression of LINC01134 mRNA	CTD	PMID:38568856
LINC01134	Human	DDE	decreases expression	EXP		6480464	Dichlorodiphenyl Dichloroethylene results in decreased expression of LINC01134 mRNA	CTD	PMID:38568856
LINC01134	Human	fipronil	multiple interactions	EXP		6480464	[fipronil co-treated with DEET] results in decreased expression of LINC01134 mRNA	CTD	PMID:28991164
LINC01134	Human	methapyrilene	affects methylation	EXP		6480464	Methapyrilene affects the methylation of LINC01134 intron	CTD	PMID:30157460
LINC01134	Human	N,N-diethyl-m-toluamide	multiple interactions	EXP		6480464	[fipronil co-treated with DEET] results in decreased expression of LINC01134 mRNA	CTD	PMID:28991164
LINC01134	Human	sodium arsenite	increases expression	EXP		6480464	sodium arsenite results in increased expression of LINC01134 mRNA	CTD	PMID:38568856
LINC01134	Human	tris(2-butoxyethyl) phosphate	affects expression	EXP		6480464	tris(2-butoxyethyl) phosphate affects the expression of LINC01134 mRNA	CTD	PMID:29024780
LINC01134	Human	valproic acid	increases methylation	EXP		6480464	Valproic Acid results in increased methylation of LINC01134 gene	CTD	PMID:29154799

PMID:12477932	PMID:34322883	PMID:35173610	PMID:35477447	PMID:37914721

Name	Type	Condition(s)	Position(s)	Clinical significance
GRCh38/hg38 1p36.32(chr1:3712088-4027367)x4	copy number gain	See cases [RCV000133657]	Chr1:3712088..4027367 [GRCh38] Chr1:3628652..4087427 [GRCh37] Chr1:3618512..3987287 [NCBI36] Chr1:1p36.32	pathogenic
GRCh38/hg38 1p36.33-36.31(chr1:844353-5827192)x3	copy number gain	See cases [RCV000134750]	Chr1:844353..5827192 [GRCh38] Chr1:779733..5887252 [GRCh37] Chr1:769596..5809839 [NCBI36] Chr1:1p36.33-36.31	pathogenic
GRCh38/hg38 1p36.33-36.32(chr1:1118636-4179080)x1	copy number loss	See cases [RCV000134211]	Chr1:1118636..4179080 [GRCh38] Chr1:1054016..4239140 [GRCh37] Chr1:1043879..4139000 [NCBI36] Chr1:1p36.33-36.32	pathogenic
GRCh38/hg38 1p36.33-36.32(chr1:844347-4398122)x1	copy number loss	See cases [RCV000134137]	Chr1:844347..4398122 [GRCh38] Chr1:779727..4458182 [GRCh37] Chr1:769590..4358042 [NCBI36] Chr1:1p36.33-36.32	pathogenic
GRCh38/hg38 1p36.33-36.31(chr1:844347-6916587)x1	copy number loss	See cases [RCV000133943]	Chr1:844347..6916587 [GRCh38] Chr1:779727..6976647 [GRCh37] Chr1:769590..6899234 [NCBI36] Chr1:1p36.33-36.31	pathogenic
GRCh38/hg38 1p36.33-36.23(chr1:844347-8171914)x1	copy number loss	See cases [RCV000136554]	Chr1:844347..8171914 [GRCh38] Chr1:779727..8231974 [GRCh37] Chr1:769590..8154561 [NCBI36] Chr1:1p36.33-36.23	pathogenic
GRCh38/hg38 1p36.33-36.32(chr1:874379-4973261)x1	copy number loss	See cases [RCV000136715]	Chr1:874379..4973261 [GRCh38] Chr1:809759..5033321 [GRCh37] Chr1:799622..4933181 [NCBI36] Chr1:1p36.33-36.32	pathogenic
GRCh38/hg38 1p36.33-36.22(chr1:844347-12470133)x1	copy number loss	See cases [RCV000136695]	Chr1:844347..12470133 [GRCh38] Chr1:779727..12530188 [GRCh37] Chr1:769590..12452775 [NCBI36] Chr1:1p36.33-36.22	pathogenic\|likely pathogenic
GRCh38/hg38 1p36.32-36.31(chr1:2906020-5336116)x1	copy number loss	See cases [RCV000137587]	Chr1:2906020..5336116 [GRCh38] Chr1:2822585..5396176 [GRCh37] Chr1:2812445..5296036 [NCBI36] Chr1:1p36.32-36.31	pathogenic
GRCh38/hg38 1p36.33-36.32(chr1:1022094-4665295)x1	copy number loss	See cases [RCV000137380]	Chr1:1022094..4665295 [GRCh38] Chr1:957474..4725355 [GRCh37] Chr1:947337..4625215 [NCBI36] Chr1:1p36.33-36.32	pathogenic
GRCh38/hg38 1p36.33-36.32(chr1:821713-3928354)x3	copy number gain	See cases [RCV000138165]	Chr1:821713..3928354 [GRCh38] Chr1:757093..3823583 [GRCh37] Chr1:746956..3834778 [NCBI36] Chr1:1p36.33-36.32	likely pathogenic
GRCh38/hg38 1p36.33-36.32(chr1:821713-5239643)x1	copy number loss	See cases [RCV000137978]	Chr1:821713..5239643 [GRCh38] Chr1:757093..5299703 [GRCh37] Chr1:746956..5199563 [NCBI36] Chr1:1p36.33-36.32	pathogenic
GRCh38/hg38 1p36.32(chr1:3695587-4084682)x3	copy number gain	See cases [RCV000137798]	Chr1:3695587..4084682 [GRCh38] Chr1:3612151..4144742 [GRCh37] Chr1:3602011..4044602 [NCBI36] Chr1:1p36.32	uncertain significance
GRCh38/hg38 1p36.33-36.31(chr1:844353-6477474)x1	copy number loss	See cases [RCV000139404]	Chr1:844353..6477474 [GRCh38] Chr1:779733..6537534 [GRCh37] Chr1:769596..6460121 [NCBI36] Chr1:1p36.33-36.31	pathogenic
GRCh38/hg38 1p36.33-36.31(chr1:821713-7000838)x1	copy number loss	See cases [RCV000138896]	Chr1:821713..7000838 [GRCh38] Chr1:757093..7060898 [GRCh37] Chr1:746956..6983485 [NCBI36] Chr1:1p36.33-36.31	pathogenic
GRCh38/hg38 1p36.33-36.32(chr1:778698-4898439)x1	copy number loss	See cases [RCV000140164]	Chr1:778698..4898439 [GRCh38] Chr1:714078..4958499 [GRCh37] Chr1:703941..4858359 [NCBI36] Chr1:1p36.33-36.32	pathogenic
GRCh38/hg38 1p36.33-36.32(chr1:821713-5099990)x1	copy number loss	See cases [RCV000141318]	Chr1:821713..5099990 [GRCh38] Chr1:757093..5160050 [GRCh37] Chr1:746956..5059910 [NCBI36] Chr1:1p36.33-36.32	pathogenic
GRCh38/hg38 1p36.33-36.31(chr1:821713-5480263)x1	copy number loss	See cases [RCV000140709]	Chr1:821713..5480263 [GRCh38] Chr1:757093..5540323 [GRCh37] Chr1:746956..5462910 [NCBI36] Chr1:1p36.33-36.31	pathogenic
GRCh38/hg38 1p36.33-36.22(chr1:914086-9567122)x1	copy number loss	See cases [RCV000141970]	Chr1:914086..9567122 [GRCh38] Chr1:849466..9627180 [GRCh37] Chr1:839329..9549767 [NCBI36] Chr1:1p36.33-36.22	pathogenic
GRCh38/hg38 1p36.32-36.23(chr1:2868477-7332569)x1	copy number loss	See cases [RCV000141437]	Chr1:2868477..7332569 [GRCh38] Chr1:2785042..7392629 [GRCh37] Chr1:2774902..7315216 [NCBI36] Chr1:1p36.32-36.23	pathogenic
GRCh38/hg38 1p36.33-36.23(chr1:898721-7811306)x1	copy number loss	See cases [RCV000142651]	Chr1:898721..7811306 [GRCh38] Chr1:834101..7871366 [GRCh37] Chr1:823964..7793953 [NCBI36] Chr1:1p36.33-36.23	pathogenic
GRCh38/hg38 1p36.33-36.22(chr1:911300-9329925)x1	copy number loss	See cases [RCV000142615]	Chr1:911300..9329925 [GRCh38] Chr1:846680..9389984 [GRCh37] Chr1:836543..9312571 [NCBI36] Chr1:1p36.33-36.22	pathogenic
GRCh38/hg38 1p36.33-36.23(chr1:844347-7870545)x1	copy number loss	See cases [RCV000142709]	Chr1:844347..7870545 [GRCh38] Chr1:779727..7930605 [GRCh37] Chr1:769590..7853192 [NCBI36] Chr1:1p36.33-36.23	pathogenic
GRCh38/hg38 1p36.33-36.32(chr1:792758-5006311)x3	copy number gain	See cases [RCV000051779]	Chr1:792758..5006311 [GRCh38] Chr1:728138..5066371 [GRCh37] Chr1:718001..4966231 [NCBI36] Chr1:1p36.33-36.32	pathogenic
GRCh38/hg38 1p36.33-36.32(chr1:826553-4719105)x3	copy number gain	See cases [RCV000051780]	Chr1:826553..4719105 [GRCh38] Chr1:761933..4779165 [GRCh37] Chr1:751796..4679025 [NCBI36] Chr1:1p36.33-36.32	pathogenic
GRCh38/hg38 1p36.33-36.31(chr1:844347-6231924)x3	copy number gain	Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051782]\|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051782]\|See cases [RCV000051782]	Chr1:844347..6231924 [GRCh38] Chr1:779727..6291984 [GRCh37] Chr1:769590..6214571 [NCBI36] Chr1:1p36.33-36.31	pathogenic
GRCh38/hg38 1p36.33-36.31(chr1:844347-5682587)x1	copy number loss	See cases [RCV000050642]	Chr1:844347..5682587 [GRCh38] Chr1:779727..5742647 [GRCh37] Chr1:769590..5665234 [NCBI36] Chr1:1p36.33-36.31	pathogenic
GRCh38/hg38 1p36.32-36.23(chr1:2844760-8007940)x1	copy number loss	See cases [RCV000051086]	Chr1:2844760..8007940 [GRCh38] Chr1:2761325..8068000 [GRCh37] Chr1:2751185..7990587 [NCBI36] Chr1:1p36.32-36.23	pathogenic
GRCh38/hg38 1p36.33-36.31(chr1:844347-6477436)x1	copy number loss	See cases [RCV000051143]	Chr1:844347..6477436 [GRCh38] Chr1:779727..6537496 [GRCh37] Chr1:769590..6460083 [NCBI36] Chr1:1p36.33-36.31	pathogenic
GRCh38/hg38 1p36.33-36.23(chr1:629025-8537745)x1	copy number loss	See cases [RCV000051993]	Chr1:629025..8537745 [GRCh38] Chr1:564405..8597804 [GRCh37] Chr1:554268..8520391 [NCBI36] Chr1:1p36.33-36.23	pathogenic
GRCh38/hg38 1p36.33-36.32(chr1:821713-4225085)x1	copy number loss	See cases [RCV000141356]	Chr1:821713..4225085 [GRCh38] Chr1:757093..4285145 [GRCh37] Chr1:746956..4185005 [NCBI36] Chr1:1p36.33-36.32	pathogenic
GRCh38/hg38 1p36.33-36.22(chr1:902111-9556305)x1	copy number loss	See cases [RCV000141577]	Chr1:902111..9556305 [GRCh38] Chr1:837491..9616363 [GRCh37] Chr1:827354..9538950 [NCBI36] Chr1:1p36.33-36.22	pathogenic
GRCh38/hg38 1p36.33-36.31(chr1:629044-7008678)x1	copy number loss	See cases [RCV000051995]	Chr1:629044..7008678 [GRCh38] Chr1:564424..7068738 [GRCh37] Chr1:554287..6991325 [NCBI36] Chr1:1p36.33-36.31	pathogenic
GRCh38/hg38 1p36.33-36.32(chr1:821713-4155674)x1	copy number loss	See cases [RCV000051996]	Chr1:821713..4155674 [GRCh38] Chr1:757093..4215734 [GRCh37] Chr1:746956..4115594 [NCBI36] Chr1:1p36.33-36.32	pathogenic
GRCh38/hg38 1p36.33-36.31(chr1:844147-5827203)x1	copy number loss	See cases [RCV000052015]	Chr1:844147..5827203 [GRCh38] Chr1:779527..5887263 [GRCh37] Chr1:769390..5809850 [NCBI36] Chr1:1p36.33-36.31	pathogenic
GRCh38/hg38 1p36.33-36.32(chr1:844147-4598532)x1	copy number loss	See cases [RCV000052017]	Chr1:844147..4598532 [GRCh38] Chr1:779527..4658592 [GRCh37] Chr1:769390..4558452 [NCBI36] Chr1:1p36.33-36.32	pathogenic
GRCh38/hg38 1p36.33-36.32(chr1:844147-5020772)x1	copy number loss	See cases [RCV000052018]	Chr1:844147..5020772 [GRCh38] Chr1:779527..5080832 [GRCh37] Chr1:769390..4980692 [NCBI36] Chr1:1p36.33-36.32	pathogenic
GRCh38/hg38 1p36.33-36.31(chr1:844347-5363885)x1	copy number loss	Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052037]\|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052037]\|See cases [RCV000052037]	Chr1:844347..5363885 [GRCh38] Chr1:779727..5423945 [GRCh37] Chr1:769590..5323805 [NCBI36] Chr1:1p36.33-36.31	pathogenic
GRCh38/hg38 1p36.33-36.22(chr1:844347-10809098)x1	copy number loss	Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052038]\|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052038]\|See cases [RCV000052038]	Chr1:844347..10809098 [GRCh38] Chr1:779727..10869155 [GRCh37] Chr1:769590..10791742 [NCBI36] Chr1:1p36.33-36.22	pathogenic
GRCh38/hg38 1p36.33-36.31(chr1:844347-5431639)x1	copy number loss	Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052039]\|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052039]\|See cases [RCV000052039]	Chr1:844347..5431639 [GRCh38] Chr1:779727..5491699 [GRCh37] Chr1:769590..5414286 [NCBI36] Chr1:1p36.33-36.31	pathogenic
GRCh38/hg38 1p36.33-36.32(chr1:844347-4665295)x1	copy number loss	See cases [RCV000052040]	Chr1:844347..4665295 [GRCh38] Chr1:779727..4725355 [GRCh37] Chr1:769590..4625215 [NCBI36] Chr1:1p36.33-36.32	pathogenic
GRCh38/hg38 1p36.33-36.23(chr1:844347-7151129)x1	copy number loss	Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052042]\|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052042]\|See cases [RCV000052042]	Chr1:844347..7151129 [GRCh38] Chr1:779727..7211189 [GRCh37] Chr1:769590..7133776 [NCBI36] Chr1:1p36.33-36.23	pathogenic
GRCh38/hg38 1p36.33-36.23(chr1:859215-8747647)x1	copy number loss	See cases [RCV000052045]	Chr1:859215..8747647 [GRCh38] Chr1:794595..8807706 [GRCh37] Chr1:784458..8730293 [NCBI36] Chr1:1p36.33-36.23	pathogenic
GRCh38/hg38 1p36.33-36.32(chr1:870177-4426613)x1	copy number loss	See cases [RCV000052063]	Chr1:870177..4426613 [GRCh38] Chr1:805557..4486673 [GRCh37] Chr1:795420..4386533 [NCBI36] Chr1:1p36.33-36.32	pathogenic
GRCh38/hg38 1p36.32-36.21(chr1:2963330-12666744)x1	copy number loss	Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053713]\|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053713]\|See cases [RCV000053713]	Chr1:2963330..12666744 [GRCh38] Chr1:2879895..12726755 [GRCh37] Chr1:2869755..12649342 [NCBI36] Chr1:1p36.32-36.21	pathogenic
GRCh38/hg38 1p36.32-36.13(chr1:3006193-17688934)x1	copy number loss	See cases [RCV000053714]	Chr1:3006193..17688934 [GRCh38] Chr1:2922757..18015429 [GRCh37] Chr1:2912617..17888016 [NCBI36] Chr1:1p36.32-36.13	pathogenic
GRCh38/hg38 1p36.32-36.22(chr1:3319336-11243395)x1	copy number loss	Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053716]\|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053716]\|See cases [RCV000053716]	Chr1:3319336..11243395 [GRCh38] Chr1:3235900..11303452 [GRCh37] Chr1:3225760..11226039 [NCBI36] Chr1:1p36.32-36.22	pathogenic
GRCh38/hg38 1p36.32-36.23(chr1:3438149-8171914)x1	copy number loss	Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053718]\|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053718]\|See cases [RCV000053718]	Chr1:3438149..8171914 [GRCh38] Chr1:3354713..8231974 [GRCh37] Chr1:3344573..8154561 [NCBI36] Chr1:1p36.32-36.23	pathogenic
GRCh38/hg38 1p36.32(chr1:2518272-4413203)	copy number gain	Anomalous pulmonary venous return [RCV003223566]	Chr1:2518272..4413203 [GRCh38] Chr1:1p36.32	uncertain significance
GRCh38/hg38 1p36.33-35.1(chr1:99125-34026935)x3	copy number gain	Trisomy 12p [RCV003447845]	Chr1:99125..34026935 [GRCh38] Chr1:1p36.33-35.1	pathogenic
GRCh38/hg38 1p36.32-36.23(chr1:3472163-7842947)x1	copy number loss	See cases [RCV000053720]	Chr1:3472163..7842947 [GRCh38] Chr1:3388727..7903007 [GRCh37] Chr1:3378587..7825594 [NCBI36] Chr1:1p36.32-36.23	pathogenic
GRCh38/hg38 1p36.33-36.31(chr1:844147-5970026)x1	copy number loss	See cases [RCV000052014]	Chr1:844147..5970026 [GRCh38] Chr1:779527..6030086 [GRCh37] Chr1:769390..5952673 [NCBI36] Chr1:1p36.33-36.31	pathogenic
GRCh38/hg38 1p36.33-36.32(chr1:872305-4133409)x1	copy number loss	See cases [RCV000052066]	Chr1:872305..4133409 [GRCh38] Chr1:807685..4193469 [GRCh37] Chr1:797548..4093329 [NCBI36] Chr1:1p36.33-36.32	pathogenic
GRCh38/hg38 1p36.33-36.31(chr1:1181847-5507243)x1	copy number loss	See cases [RCV000052070]	Chr1:1181847..5507243 [GRCh38] Chr1:1117227..5567303 [GRCh37] Chr1:1107090..5489890 [NCBI36] Chr1:1p36.33-36.31	pathogenic
GRCh38/hg38 1p36.32(chr1:2683403-4729121)x1	copy number loss	See cases [RCV000052073]	Chr1:2683403..4729121 [GRCh38] Chr1:2614842..4789181 [GRCh37] Chr1:2604702..4689041 [NCBI36] Chr1:1p36.32	pathogenic

Predicted Target Of

	Summary Value
Count of predictions:	603
Count of miRNA genes:	489
Interacting mature miRNAs:	535
Transcripts:	ENST00000413332, ENST00000439488, ENST00000442673
Prediction methods:	Miranda, Rnahybrid
Result types:	miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.

The following QTLs overlap with this region.

RGD ID	Symbol	Name	LOD	P Value	Trait	Sub Trait	Chr	Start	Stop	Species
1298451	OSTEAR17_H	Osteoarthritis QTL 17 (human)	2.4	0.0004	Joint/bone inflammation	osteoarthritis	11	1	25188105	Human
597462613	GWAS1558687_H	prostate cancer QTL GWAS1558687 (human)		0.000002	prostate cancer		1	3910062	3910063	Human
1298463	BP9_H	Blood pressure QTL 9 (human)	3.9		Blood pressure	hypertension susceptibility	1	1	25188105	Human

Click on a value in the shaded box below the category label to view a detailed expression data table for that system.

adipose tissue	alimentary part of gastrointestinal system	appendage	circulatory system	ectoderm	endocrine system	endoderm	entire extraembryonic component	exocrine system	hemolymphoid system	hepatobiliary system	integumental system	mesenchyme	mesoderm	musculoskeletal system	nervous system	renal system	reproductive system	respiratory system	sensory system
1160	2385	2569	2076	4781	1684	2284	5	616	1894	460	2170	7026	6171	52	3530	840	1708	1555	170


RefSeq Transcripts	NR_024455	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
GenBank Nucleotide	AK130173	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC016994	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC017122	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC062787	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BX005110	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CP068277	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CR847867	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles

Ensembl Acc Id:

ENST00000413332

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	1	3,900,347 - 3,906,110 (+)	Ensembl

Ensembl Acc Id:

ENST00000439488

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	1	3,900,390 - 3,915,447 (+)	Ensembl

Ensembl Acc Id:

ENST00000442673

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	1	3,900,347 - 3,917,225 (+)	Ensembl

Ensembl Acc Id:

ENST00000667408

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	1	3,900,347 - 3,914,654 (+)	Ensembl

Ensembl Acc Id:

ENST00000686089

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	1	3,900,349 - 3,917,547 (+)	Ensembl

Ensembl Acc Id:

ENST00000693306

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	1	3,900,349 - 3,906,036 (+)	Ensembl

Ensembl Acc Id:

ENST00000757265

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	1	3,900,361 - 3,916,596 (+)	Ensembl

Ensembl Acc Id:

ENST00000757266

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	1	3,900,353 - 3,915,462 (+)	Ensembl

Ensembl Acc Id:

ENST00000757267

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	1	3,900,403 - 3,915,447 (+)	Ensembl

Ensembl Acc Id:

ENST00000757268

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	1	3,900,384 - 3,914,865 (+)	Ensembl

Ensembl Acc Id:

ENST00000757269

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	1	3,900,406 - 3,914,855 (+)	Ensembl

Ensembl Acc Id:

ENST00000757270

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	1	3,900,432 - 3,914,662 (+)	Ensembl

Ensembl Acc Id:

ENST00000757271

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	1	3,900,187 - 3,906,110 (+)	Ensembl

Ensembl Acc Id:

ENST00000757272

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	1	3,900,363 - 3,906,091 (+)	Ensembl

Ensembl Acc Id:

ENST00000757273

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	1	3,900,355 - 3,906,036 (+)	Ensembl

Ensembl Acc Id:

ENST00000757274

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	1	3,900,443 - 3,906,036 (+)	Ensembl

Ensembl Acc Id:

ENST00000757275

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	1	3,900,401 - 3,905,966 (+)	Ensembl

Ensembl Acc Id:

ENST00000757276

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	1	3,900,577 - 3,906,036 (+)	Ensembl

Ensembl Acc Id:

ENST00000757277

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	1	3,900,349 - 3,905,191 (+)	Ensembl

Ensembl Acc Id:

ENST00000757278

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	1	3,900,395 - 3,905,202 (+)	Ensembl

Ensembl Acc Id:

ENST00000757279

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	1	3,900,406 - 3,905,212 (+)	Ensembl

Ensembl Acc Id:

ENST00000757280

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	1	3,900,417 - 3,905,191 (+)	Ensembl

Ensembl Acc Id:

ENST00000757281

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	1	3,903,706 - 3,905,938 (+)	Ensembl

Ensembl Acc Id:

ENST00000757282

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	1	3,900,347 - 3,900,841 (+)	Ensembl

RefSeq Acc Id:

NR_024455

RefSeq Status:

VALIDATED

Type:

NON-CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	1	3,900,404 - 3,915,447 (+)	NCBI
GRCh37	1	3,816,968 - 3,832,011 (+)	NCBI
HuRef	1	3,112,576 - 3,127,620 (+)	NCBI
CHM1_1	1	3,804,016 - 3,819,059 (+)	NCBI
T2T-CHM13v2.0	1	3,412,308 - 3,427,355 (+)	NCBI

Sequence:

show sequence

ACACTGGAGCAGGAAGTCGGCCTGTGGCCGGCCATGTTCATGAGGGCGCGTCCCTTGGCACCCCTGTAGCCGCTATGTTTCCCACGCCCGTGGCAGGCCTGAGAGATTATGTTTGCGGGGGGTGCTTT
TTTTGTAGCTTCTGTGTTCGCCATATTTGAAAGGGGCAGACGGCCATGTTCGTGAACGGCGCTTCCCTTGGTGCACCTGTGGCCGCCATGTTTGAGCGAGGACCCCGTGGCAGGCCAGGACCGTTTCT
CCGGTGCTATCCCAGAGCATGGCGCATCCACTCATTCACTCAAGGGAAAGGCCTGAAAGTAAAATTGTATCAACATTAGGTTTGGCTAATGTTGCCATTAGGCAAACCTAATTTTAATGAAGCCAGGA
GGTTCTCGTTTTGGGCCTTGACTGGACAGGTTTGAGCTAGAAACCACTTGAAGTATTGATCATCCATCTGATCATCAAGTTTTTTTTTTTTTTTGAGTTGGAGTCTCACTCTGTTGCTCACGCTGGAG
TGCAGTGGCACGATCTCAGCTCCCTGCAACCTCCACCTCCCGGGTTCTCCTGCCTCAGCCTTCCAAGTAGCTGGGATTATAAGCGTGTGCCACCATGCCTGGCTACTTTTTTATATTTTCGGTTGAGA
TGGGGTTTCACCGCGTGGCCAGGCTGGTCTCAAACTCCTGACCTCAAGTGATCCGCCTGCCTCGGCCTCCCAAAGTGCTGGGATTACAGGCGTGAGCCGCCACTCCCAGCTTGTTCATCCAGTTTTTA
TTGAGCATCTATTATGTGCCGATATTGAGGTAGACTCTGGGAGTCACAGCAGTGAATGCAGCTGCCTGGATGCCTCGTGAGGGCCGGAGCCTCACTGGGGAGATGGACATGAACAGCAAATGCACAGC
GAGGAAAGCCAGGGGTCTGTGCGGGGATGCTGCAGGACACGAGAACCAGCCAAGACCTATGGCCCCTGCAGCCACCGAGGGCTCGAGAGCGCCCCTGTGGACTTGGCTGGGCCCTTCATGGTGACATC
CAGGAATGCGGCTGAGCGCGGGTGTTGACCTCGCTGTTTGCTGGAATGTTTGGGTTCTTGGACCATGTCAGTGACGGCTGTGTCACCATGGCCTTGCTATCCCCAGGAAAACCTAACATGCACCCCGC
GCCTGTCCTCTGGGACTCCCATCCTCCTCCTTTGTCTGACCCCTGAGAGGCTTACCGTTTCCCCAGGGCAGCCCCGGCTGTGGCCCTCGGCCCTGCTCCAGGCGGCCATGTCAGTGTCCTCCCTCGGC
GCTCCCAACACCCTACCTGGCTCTGCGATGGCCACCCTGGACTCCTAAACACCCCAGAAAGGGAAGAGATTTAAGAGGAACCTTGATTCCTGCCATTCTGCGCAGTCGTGGGTCCCTCCTCCACCTGG
GGCCCTCAAGGGGATTTCTGTCCGCACTCCCAGCCAGCGACCCCTCCCAGTTCCTGCAGCTGGAGCGGCCCTCTCTCCTGAACATTCGGGCACCTGCGTCTGTCACTGCAGCCAGAGGGCTGGAGTGT
CTTCGGTCAACTCGCCATCCCTGCCACGGCTGGAGGCCACATGTCCCAGAACCTACCTTGCTGGGATGGGGGTTGGGGTGGCAGAGGCTGAACGCGTGTGAGGTTTGGGGGAGGACAAGCGGAGCGGG
GATGTGTGGGAGGTCCTGGTGTCCACCGTGAGGATGGTCACACCCCATAGCTTTGTTGATGCTGTGGCTGTAGCAGGCCCAGTGGCTCCGCTGAGCCTCCCTAGCACCAGTGCCCAGTGAAGTGTGGG
GGGCTGGACATAGGTGGCCTCAGTTCCTGGGACTCCCCCAAAGCTCTGGTTTCCCCCCTGCTCCCAGGCTTCAGGTGGACGAGTTAGTGACCACCCCCACTCCAGACCTCCCTCCCCTAGCCACCCCC
ACAGTTATAAAAACCTTCATTCTCATATGGAAAAAAAAAAAAAAA

hide sequence

RGD ID:

15095188

Promoter ID:

EPDNEWNC_H10

Type:

initiation region

Name:

LINC01134_1

Description:

long intergenic non-protein coding RNA 1134 [Source:HGNCSymbol;Acc:HGNC:49449]

SO ACC ID:

SO:0000170

Source:

EPDNEWNC (Eukaryotic Promoter Database, http://epd.vital-it.ch/)

Experiment Methods:

Single-end sequencing.; Paired-end sequencing.

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	1	3,900,401 - 3,900,461	EPDNEWNC

Database	Acc Id	Source(s)
COSMIC	LINC01134	COSMIC
Ensembl Genes	ENSG00000236423	Ensembl, ENTREZGENE
Ensembl Transcript	ENST00000439488	ENTREZGENE
GTEx	ENSG00000236423	GTEx
HGNC ID	HGNC:49449	ENTREZGENE
Human Proteome Map	LINC01134	Human Proteome Map
NCBI Gene	LINC01134	ENTREZGENE
RNAcentral	URS000054846A	RNACentral
	URS0000759EB6	RNACentral
	URS00022B17A6	RNACentral
	URS00022B6820	RNACentral
	URS00022B7788	RNACentral
	URS00025F085C	RNACentral
	URS00025F7E1B	RNACentral

Gene Annotator (Functional Annotation) unavailable	Gene Annotator (Annotation Distribution) unavailable	Variant Visualizer (Genomic Variants) unavailable


InterViewer (Protein-Protein Interactions) unavailable	Gviewer (Genome Viewer) unavailable	Variant Visualizer (Damaging Variants) unavailable


Gene Annotator (Annotation Comparison) unavailable	OLGA (Gene List Generator) unavailable
		Excel (Download)

MOET (Multi-Ontology Enrichement) unavailable	GOLF (Gene-Ortholog Location Finder) unavailable

Send us a Message